In This Section

NextGen Stars

AACR Annual Meeting 2023 NextGen Stars Program 

The application is closed. The application deadline was October 4, 2022.

Application Process

  • Applicants must be AACR Associate Members or Active Members who are not above the level of Assistant Professor or equivalent. Please note that you must be an AACR member in good standing (dues paid for the current year) in order to submit an application. Applicants who do not meet these criteria will not be able to apply. Nonmembers are encouraged to apply for AACR membership. You may either submit the Official AACR Membership Application online or download the application and submit it to the AACR office with the required documents. Please allow 30 days for application review and approval notification. Visit www.aacr.org/Membership or contact [email protected] with any questions. 
  • Applications consist of an extended abstract (limit 8,000 characters including spaces), a CV, and a letter of recommendation from your P.I., department head, or another mentor who is familiar with your work. Only complete applications will be considered. The application deadline is 5:00 p.m. ET, Tuesday, October 4, 2022. No late applications will be considered. All applications must be submitted online through myAACR. 
  • Between 8 and 12 applicants will be chosen to give a talk, regardless of the number of applications received. 

Information for Selected Presenters

  • Selected talks will be added to existing Major Symposia and Advances sessions, based on the subject matter of the abstract. Most talks will be 15 minutes in length plus 5 minutes for discussion, but the assigned length of the talk may vary depending on the session. 
  • Applicants who are selected to give talks at the Annual Meeting will receive travel support and complimentary registration for the meeting. 

Note Regarding Regular Abstract Submission

  • The submission of an extended abstract through this NextGen Stars application process is completely separate from the submission of a regular abstract for the AACR Annual Meeting. Applicants will be notified of their status by early November. Those who are not selected as a NextGen Star but still wish to submit an abstract to the Annual Meeting must submit a separate abstract through the normal abstract submission process by the regular abstract deadline of Thursday, November 17, 2022. 

Congratulations to the 2022 NextGen Stars!

Mustapha Abubakar, MD, PhD

Mustapha Abubakar, MD, PhD

Research Fellow, Division of Cancer Epidemiology and Genetics

National Cancer Institute, Rockville, Maryland

Double-edged “soil”: Stromal microenvironment in breast cancer

Major Symposium SY25

Metabolic and Nutritional Regulation of Cancer and Immunity

Tuesday, April 12, 2022

Ana Luisa Correia, PhD

Ana Luisa Correia, PhD

Principal Investigator, Cancer Dormancy and Immunity Lab

Champalimaud Foundation, Lisbon, Portugal

Revisiting NK cell immunity to prevent metastasis

Major Symposium SY31

Tumor Dormancy

Sunday, April 10, 2022

Isra Elhussin, MBBS, MSc, PhD candidate

Isra Elhussin, MBBS, MSc, PhD candidate

Tuskegee University, Tuskegee, Alabama

Prostate cancer: Multi-omics comparison between European, African American, and Native African men with prostate cancer

 

Advances in Organ Site Research AOS08

The Next Generation of Targets for Prostate Cancer

Monday, April 11, 2022

Ekrem Emrah Er, PhD

Ekrem Emrah Er, PhD

Assistant Professor, Department of Physiology and Biophysics

University of Illinois at Chicago, Chicago, IL

Elevated cellular stiffness sensitizes metastatic cells to destruction by mechanosurveillance: The mechanical mode of immune surveillance

Major Symposium SY23

Extracellular Matrix Remodeling in Cancer

Tuesday, April 12, 2022

Ariella Hanker, PhD

Ariella Hanker, PhD

Assistant Professor, Simmons Comprehensive Cancer Center

The University of Texas Southwestern Medical Center, Dallas, Texas

It takes two: Cooperating oncogenic mutations in the HER2/HER3 pathway

 

Advances in Organ Site Research AOS02

Triple Negative Breast Cancer: Molecular Insights and Treatment Advances

Monday, April 11, 2022

Daniel Herranz, PharmD, PhD

Daniel Herranz, PharmD, PhD

Assistant Professor of Pharmacology

Rutgers Cancer Institute, New Brunswick, New Jersey

Identification of SIRT1 as a novel therapeutic target in T-ALL

 Major Symposium SY04

Epigenetic Alterations as Cancer Therapeutic Targets

Monday, April 11, 2022

Sarah J. Hill, MD, PhD

Sarah J. Hill, MD, PhD

Assistant Professor, Medical Oncology/Molecular and Cellular Oncology

Dana-Farber Cancer Institute, Boston, Massachusetts

Dissecting mechanisms of NK cell dysfunction and re-engagement in high grade serous ovarian cancer

 Advances in Organ Site Research AOS10

Advances in Ovarian Cancer Screening and Treatment

Monday, April 11, 2022

William L. Hwang, MD, PhD

William L. Hwang, MD, PhD

Radiation Oncologist and Research Fellow

Massachusetts General Hospital Cancer Center/Harvard Medical School, Boston, Massachusetts

Multicellular spatial community featuring a novel neuronal-like malignant phenotype is enriched in pancreatic cancer after neoadjuvant chemotherapy and radiotherapy

 Major Symposium SY12

 Nerves, Cancer, and Immunity

 Monday, April 11, 2022

Anand G. Patel, MD, PhD

Anand G. Patel, MD, PhD

Instructor, Department of Oncology

St. Jude Children’s Research Hospital, Memphis, Tennessee

The myogenesis program drives clonal selection and drug resistance in pediatric rhabdomyosarcoma

Advances in Organ Site Research AOS09

Models for Rare Cancers

Tuesday, April 12, 2022

Arja Ray, PhD

Arja Ray, PhD

Postdoctoral Fellow, Department of Pathology

University of California San Francisco, San Francisco, California

Next-generation macrophage and T cell activation reporters to define functional immune states in solid tumors

 Major Symposium SY19

Myeloid Cell Control of Therapeutic Antitumor Immunity

Tuesday, April 12, 2022

Marcus Ruscetti, PhD

Marcus Ruscetti, PhD

Assistant Professor, Department of Molecular Cell and Cancer Biology

University of Massachusetts Chan Medical School, Worcester, Massachusetts

 Modulating cellular senescence to reinstate natural killer cell immunity for pancreatic cancer immunotherapy

 Major Symposium SY24

Aging and the Tumor Microenvironment’s Impact on Minimal Residual Disease    and Cancer Recurrence

Wednesday, April 13, 2022

Ayesha Shafi, PhD

Ayesha Shafi, PhD

Assistant Professor, Center for Prostate Disease Research

Uniformed Services University of the Health Sciences/The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland

The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

 Presidential Select Symposium SY33

Aging, Stress, and Cancer

 Monday, April 11, 2022

Katherine Tossas, PhD, MS

Katherine Tossas, PhD, MS

Assistant Professor, Department of Health Behavior & Policy

Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia

The vaginal microbiome may operate differently by race to precipitate the risk of pre-cervical cancer

 Advances in Population Sciences APS01

Where You Live Matters: From Biological to Social Determinants of Cancer Outcomes

Tuesday, April 12, 2022

Derek Wainwright, PhD

Derek Wainwright, PhD

Assistant Professor, Departments of Neurological Surgery, Medicine, and Immunology

Northwestern University Feinberg School of Medicine, Chicago, Illinois

IDO: Going beyond enzyme activity to eradicate glioblastoma

 Advances in Organ Site Research AOS13

Advances in Glioblastoma Cancer Research and Cancer Care

Monday, April 11, 2022